Research Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Long-term outcomes of daratumumab, bortezomib, and dexamethasone in previously treated patients with multiple myeloma.

Long-term outcomes of daratumumab, bortezomib, and dexamethasone in previously treated patients with multiple myeloma.

Posted by on Sep 20, 2020 in Multiple Myeloma | 0 comments

In a nutshell This trial was carried out to examine the long-term safety and effectiveness of daratumumab (Darzalex) plus bortezomib (Velcade) and dexamethasone (Dexasone) in patients with previously treated multiple myeloma (MM). The authors concluded that after 3-years this treatment maintained benefit and...

Read More

Managing non-ST elevation myocardial infarction in the elderly – is an invasive or non-invasive approach more suitable?

Managing non-ST elevation myocardial infarction in the elderly – is an invasive or non-invasive approach more suitable?

Posted by on Sep 20, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated the management of non-ST elevation myocardial infarction (NSTEMI) in elderly patients. They found that invasive management had better survival rates for these patients.  Some background Coronary artery disease (CAD) is caused by reduced blood flow to the heart. This can be caused by blockages. CAD can...

Read More

Does freezing of embryos improve live birth rates in women of advanced reproductive age?

Does freezing of embryos improve live birth rates in women of advanced reproductive age?

Posted by on Sep 20, 2020 in Infertility | 0 comments

In a nutshell This study investigated live birth rates (LBRs) in women that underwent frozen (Fz) embryo transfer (ET).  They found that LBRs were higher with Fz-ET in women under 35, but there was no difference between Fz and fresh (Fr) ET in those older than 35. Some background Infertility is a common condition. Assisted reproductive technology...

Read More

The impact of G-CSF on brentuximab vedotin plus chemotherapy in treating newly diagnosed advanced Hodgkin lymphoma

The impact of G-CSF on brentuximab vedotin plus chemotherapy in treating newly diagnosed advanced Hodgkin lymphoma

Posted by on Sep 20, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated the impact of granulocyte-colony stimulating factor (G-CSF; Neupogen) on the outcomes of brentuximab-vedotin (BV; Adcetris) plus chemotherapy in newly diagnosed patients with stage-III/IV Hodgkin lymphoma (HL). The authors found that G-CSF improved the safety and efficacy outcomes of the combination therapy in such...

Read More

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Posted by on Sep 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D). It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients. Some background T2D is a...

Read More

Real-time vs flash monitoring for T1D

Real-time vs flash monitoring for T1D

Posted by on Sep 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared real-time continuous glucose monitoring (CGM) to flash CGM for patients with type 1 diabetes (T1D). It found that real-time CGM led to better glucose control and less hypoglycemia, both during daily activity and exercise. Some background Patients with T1D are unable to create the hormone insulin to regulate blood...

Read More

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Posted by on Sep 20, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of a gentler stem cell transplant (SCT) from a partially matched donor for patients with advanced lymphoma. It found that haploidentical SCT is an effective treatment option for these patients. Some background Lymphomas are a group of cancers of white blood cells within the lymph nodes. Common types...

Read More

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Posted by on Sep 20, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at the effect of a gentler stem cell transplant (SCT) from a partially matched donor for patients with advanced lymphoma. It found that haploidentical SCT is an effective treatment option for these patients. Some background Lymphomas are a group of cancers of white blood cells within the lymph nodes. Common types...

Read More

Repetitive transcranial magnetic stimulation improves the treatment outcomes of patients with Parkinson’s disease

Repetitive transcranial magnetic stimulation improves the treatment outcomes of patients with Parkinson’s disease

Posted by on Sep 20, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of repetitive transcranial magnetic stimulation (RTMS) in the treatment of patients with Parkinson's disease (PD). Researchers suggested that RTMS improves walking ability in these patients. Some background PD affects brain cells, which are responsible for controlling body functions. This...

Read More

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Posted by on Sep 19, 2020 in Overactive bladder | 0 comments

In a nutshell This study reviewed the outcomes of onabotulinumtoxinA (BTX) and sacral neuromodulation (SNM) in the treatment of overactive bladder (OAB). Researchers suggested that both treatments improved the outcomes of these patients, but BTX may be associated with more complications. Some background OAB of an uncontrolled need to urinate...

Read More

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Posted by on Sep 19, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study reviewed the effectiveness of water vapor thermal therapy (WVTT) as a treatment for urinary symptoms related to benign prostatic hyperplasia (BPH). Researchers suggested that this therapy improves the outcomes of these patients. Some background BPH consists of the enlargement of the prostate gland and is a common condition in...

Read More